Dermata Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
342
across all filing types
Latest filing
2026-05-29
Regulatory Filings
Country
US
United States of America
Listing
US
DRMA
Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B3 | 2026-05-29 | English | |
| 8-K | 2026-05-27 | English | |
| S-3/A | 2026-05-22 | English | |
| ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47894784 | 424B3 | 2026-05-29 | English | ||
| 47845266 | 8-K | 2026-05-27 | English | ||
| 46861885 | S-3/A | 2026-05-22 | English | ||
| 34662829 | ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 34662700 | DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 32968155 | 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English | ||
| 32899840 | 8-K - DERMATA THERAPEUTICS, INC. (0001853816) (Filer) | 2026-02-25 | English | ||
| 32075223 | SCHEDULE 13G/A Filing | 2026-02-18 | English | ||
| 32075176 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18542004 | SCHEDULE 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject) | 2026-02-09 | English | ||
| 32075231 | 8-K Filing | 2026-02-03 | English | ||
| 32075139 | SCHEDULE 13D/A Filing | 2026-02-02 | English | ||
| 32075157 | 424B3 Filing | 2026-01-29 | English | ||
| 13422563 | 424B5 | 2026-01-27 | English | ||
| 32075201 | 8-K Filing | 2026-01-27 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Dermata Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35467/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35467 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35467 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35467 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35467}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dermata Therapeutics, Inc. (id: 35467)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.